These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 25727856)

  • 21. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
    Hyldgaard C
    Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study.
    Mura M; Porretta MA; Bargagli E; Sergiacomi G; Zompatori M; Sverzellati N; Taglieri A; Mezzasalma F; Rottoli P; Saltini C; Rogliani P
    Eur Respir J; 2012 Jul; 40(1):101-9. PubMed ID: 22241745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lung Cancer in Patients with Severe Idiopathic Pulmonary Fibrosis: Critical Aspects.
    Bargagli E; Bonti V; Ferrari K; Rosi E; Bindi A; Bartolucci M; Chiara M; Voltolini L
    In Vivo; 2017; 31(4):773-777. PubMed ID: 28652456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis: a proof of concept study.
    Tsushima K; Yamaguchi K; Kono Y; Yokoyama T; Kubo K; Matsumura T; Ichimura Y; Abe M; Terada J; Tatsumi K
    Pulm Pharmacol Ther; 2014 Dec; 29(2):233-40. PubMed ID: 24836398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of the risk stratification score in idiopathic pulmonary fibrosis: study protocol of a prospective, multi-centre, observational, 3-year clinical trial.
    Manzetti GM; Hosein K; Cecchini MJ; Kwan K; Abdelrazek M; Zompatori M; Rogliani P; Mura M
    BMC Pulm Med; 2021 Dec; 21(1):396. PubMed ID: 34863146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acute exacerbations of idiopathic pulmonary fibrosis].
    Lazor R; Bonetti A; Nicod LP
    Rev Med Suisse; 2010 Nov; 6(272):2228-30, 2232. PubMed ID: 21207734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 15-step oximetry test: a reliable tool to identify candidates for lung transplantation among patients with idiopathic pulmonary fibrosis.
    Shitrit D; Rusanov V; Peled N; Amital A; Fuks L; Kramer MR
    J Heart Lung Transplant; 2009 Apr; 28(4):328-33. PubMed ID: 19332258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review.
    Luppi F; Cerri S; Taddei S; Ferrara G; Cottin V
    Intern Emerg Med; 2015 Jun; 10(4):401-11. PubMed ID: 25672832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung cancer in patients with idiopathic pulmonary fibrosis: clinical characteristics and impact on survival.
    Lee T; Park JY; Lee HY; Cho YJ; Yoon HI; Lee JH; Jheon S; Lee CT; Park JS
    Respir Med; 2014 Oct; 108(10):1549-55. PubMed ID: 25175479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Management of acute exacerbations of pulmonary fibrosis].
    Naccache JM; Mal H
    Rev Mal Respir; 2011 Apr; 28(4):517-28. PubMed ID: 21549906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idiopathic pulmonary fibrosis: current concepts.
    Ryu JH; Colby TV; Hartman TE
    Mayo Clin Proc; 1998 Nov; 73(11):1085-101. PubMed ID: 9818046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Idiopathic pulmonary fibrosis in a referral center in Iran: are patients developing the disease at a younger age?
    Hashemi Sadraei N; Riahi T; Masjedi MR
    Arch Iran Med; 2013 Mar; 16(3):177-81. PubMed ID: 23432171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and functional outcomes in Middle Eastern patients with idiopathic pulmonary fibrosis.
    Alhamad EH; Masood M; Shaik SA; Arafah M
    Clin Respir J; 2008 Oct; 2(4):220-6. PubMed ID: 20298338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A retrospective cohort study of prognostic factors for death in patients with idiopathic pulmonary fibrosis].
    Li ZH; Peng SC; Kang J; Hou XM; Yu RJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Dec; 33(12):887-91. PubMed ID: 21211406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary hypertension in idiopathic pulmonary fibrosis: a review.
    Pitsiou G; Papakosta D; Bouros D
    Respiration; 2011; 82(3):294-304. PubMed ID: 21677422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New treatment and markers of prognosis for idiopathic pulmonary fibrosis: lessons learned from translational research.
    Baroke E; Gauldie J; Kolb M
    Expert Rev Respir Med; 2013 Oct; 7(5):465-78. PubMed ID: 24138691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical impact of major comorbidities on idiopathic pulmonary fibrosis.
    Suzuki A; Kondoh Y
    Respir Investig; 2017 Mar; 55(2):94-103. PubMed ID: 28274539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Retrospective analysis of the prognosis factors in patients with idiopathic pulmonary fibrosis].
    Zhang J; Huang H; Lu ZW; Xu ZJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Mar; 34(3):174-8. PubMed ID: 21569682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Idiopathic pulmonary fibrosis: diagnosis and prognostic evaluation.
    Poletti V; Ravaglia C; Buccioli M; Tantalocco P; Piciucchi S; Dubini A; Carloni A; Chilosi M; Tomassetti S
    Respiration; 2013; 86(1):5-12. PubMed ID: 23816667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of survival in idiopathic interstitial pneumonia.
    Carbone R; Bottino G; Paredi P; Shah P; Meyer KC
    Eur Rev Med Pharmacol Sci; 2010 Aug; 14(8):695-704. PubMed ID: 20707290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.